Revance Therapeutics Statistics
Total Valuation
RVNC has a market cap or net worth of $252.76 million. The enterprise value is $450.92 million.
| Market Cap | 252.76M |
| Enterprise Value | 450.92M |
Important Dates
The next estimated earnings date is Tuesday, August 6, 2024, after market close.
| Earnings Date | Aug 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
RVNC has 104.45 million shares outstanding. The number of shares has increased by 13.29% in one year.
| Shares Outstanding | 104.45M |
| Shares Change (YoY) | +13.29% |
| Shares Change (QoQ) | +5.72% |
| Owned by Insiders (%) | 8.55% |
| Owned by Institutions (%) | 86.43% |
| Float | 83.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.07 |
| Forward PS | 0.82 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.91 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.37
| Current Ratio | 5.37 |
| Quick Ratio | 4.46 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -14.76 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -60.00% |
| Return on Capital (ROIC) | -81.03% |
| Revenue Per Employee | $396,390 |
| Profits Per Employee | -$531,566 |
| Employee Count | 597 |
| Asset Turnover | 0.45 |
| Inventory Turnover | 1.87 |
Taxes
In the past 12 months, RVNC has paid $300,000 in taxes.
| Income Tax | 300,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -90.35% in the last 52 weeks. The beta is 1.05, so RVNC's price volatility has been similar to the market average.
| Beta (5Y) | 1.05 |
| 52-Week Price Change | -90.35% |
| 50-Day Moving Average | 3.13 |
| 200-Day Moving Average | 6.22 |
| Relative Strength Index (RSI) | 36.58 |
| Average Volume (20 Days) | 1,690,664 |
Short Selling Information
The latest short interest is 14.35 million, so 13.74% of the outstanding shares have been sold short.
| Short Interest | 14.35M |
| Short Previous Month | 12.76M |
| Short % of Shares Out | 13.74% |
| Short % of Float | 17.16% |
| Short Ratio (days to cover) | 7.46 |
Income Statement
In the last 12 months, RVNC had revenue of $236.65 million and -$317.35 million in losses. Loss per share was -$3.64.
| Revenue | 236.65M |
| Gross Profit | 163.54M |
| Operating Income | -305.57M |
| Pretax Income | -317.05M |
| Net Income | -317.35M |
| EBITDA | -287.87M |
| EBIT | -296.93M |
| Loss Per Share | -$3.64 |
Balance Sheet
The company has $277.62 million in cash and $475.78 million in debt, giving a net cash position of -$198.16 million or -$1.90 per share.
| Cash & Cash Equivalents | 277.62M |
| Total Debt | 475.78M |
| Net Cash | -198.16M |
| Net Cash Per Share | -$1.90 |
| Equity (Book Value) | -98.67M |
| Book Value Per Share | -0.94 |
| Working Capital | 300.78M |
Cash Flow
In the last 12 months, operating cash flow was -$213.01 million and capital expenditures -$7.73 million, giving a free cash flow of -$220.74 million.
| Operating Cash Flow | -213.01M |
| Capital Expenditures | -7.73M |
| Free Cash Flow | -220.74M |
| FCF Per Share | -$2.40 |
Margins
Gross margin is 69.11%, with operating and profit margins of -129.13% and -134.10%.
| Gross Margin | 69.11% |
| Operating Margin | -129.13% |
| Pretax Margin | -133.97% |
| Profit Margin | -134.10% |
| EBITDA Margin | -121.65% |
| EBIT Margin | -125.47% |
| FCF Margin | -93.28% |
Dividends & Yields
RVNC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.29% |
| Shareholder Yield | -13.29% |
| Earnings Yield | -125.55% |
| FCF Yield | -87.33% |
Analyst Forecast
The average price target for RVNC is $12.00, which is 395.87% higher than the current price. The consensus rating is "Buy".
| Price Target | $12.00 |
| Price Target Difference | 395.87% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 25.85% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
RVNC has an Altman Z-Score of -6.38 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.38 |
| Piotroski F-Score | 4 |